Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 166

Similar articles for PubMed (Select 24370352)

1.

Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy.

Sofocleous CT, Garcia AR, Pandit-Taskar N, Do KG, Brody LA, Petre EN, Capanu M, Longing AP, Chou JF, Carrasquillo JA, Kemeny NE.

Clin Colorectal Cancer. 2014 Mar;13(1):27-36. doi: 10.1016/j.clcc.2013.11.010. Epub 2013 Nov 13.

PMID:
24370352
2.

WE-AB-204-02: Molecular-Imaging Based Assessment of Liver Complications for Yttrium-90 Microsphere Treatments: Can Existing NTCP Models Explain Clinical Outcomes?

Lin M, Choi E, Chuong M, Saboury B, Moeslein F, D'Souza W, Guerrero M.

Med Phys. 2015 Jun;42(6):3659. doi: 10.1118/1.4925878.

PMID:
26129178
3.

Sirt-ainly Aire.

Peterson P.

Nat Immunol. 2015 Jun 18;16(7):680-1. doi: 10.1038/ni.3195. No abstract available.

PMID:
26086133
4.

Gastric Perforation Following Prophylactic Embolization of Right Gastric and Gastroduodenal Arteries Prior to Selective Internal Radiation Therapy.

Shukla PA, Ahuja J, Kurli V, Patel RI, Kozuch PS.

Cardiovasc Intervent Radiol. 2015 Jun 13. [Epub ahead of print]

PMID:
26071106
5.

Managing liver metastases in NETS: Radionuclide therapy and selective internal radiation therapy [SIRT].

Lewington V.

Regul Pept. 2010 Sep 9;164(1):3. doi: 10.1016/j.regpep.2010.07.008. Epub 2010 Aug 20. No abstract available.

PMID:
26009322
6.

Dramatic response to selective internal radiation therapy for unresectable hepatocellular carcinoma.

Park WD, Li BT, Maher R, Samra JS, Clarke S, Bernard EJ, Bailey DL, Pavlakis N.

Oxf Med Case Reports. 2015 Feb 20;2015(2):194-5. doi: 10.1093/omcr/omv007. eCollection 2015 Feb.

7.

Interventional oncology for liver and lung metastases from colorectal cancer: The current state of the art.

de Baere T, Tselikas L, Pearson E, Yevitch S, Boige V, Malka D, Ducreux M, Goere D, Elias D, Nguyen F, Deschamps F.

Diagn Interv Imaging. 2015 Jun;96(6):647-54. doi: 10.1016/j.diii.2015.04.004. Epub 2015 May 16.

PMID:
25985998
8.

[Chemoembolization for unresectable colorectal liver metastases with drug-eluting microspheres].

Skupchenko AV, Lysenko AV, Korolev DG, Skobel'tsov DA, Rassudishkin AS.

Vestn Rentgenol Radiol. 2014 Nov-Dec;(6):33-8. Russian.

PMID:
25975131
9.

Cost-effectiveness of selective internal radiation therapy using yttrium-90 resin microspheres in treating patients with inoperable colorectal liver metastases in the UK.

Pennington B, Akehurst R, Wasan H, Sangro B, Kennedy AS, Sennfält K, Bester L.

J Med Econ. 2015 Jun 9:1-8. [Epub ahead of print]

PMID:
25941769
10.

(P050) Yttrium-90 Radioembolization for Unresectable, Chemorefractory Colorectal Cancer Liver Metastases in KRAS Wild-type and Mutant Patients.

[No authors listed]

Oncology (Williston Park). 2015 Apr 21;29(4 Suppl 1). pii: 205006. No abstract available.

11.

A single-center experience in radioembolization as salvage therapy of hepatic metastases of uveal melanoma.

Schelhorn J, Richly H, Ruhlmann M, Lauenstein TC, Theysohn JM.

Acta Radiol Open. 2015 Apr 6;4(4):2047981615570417. doi: 10.1177/2047981615570417. eCollection 2015 Apr.

12.

Fusion dual-tracer SPECT-based hepatic dosimetry predicts outcome after radioembolization for a wide range of tumour cell types.

Lam MG, Banerjee A, Goris ML, Iagaru AH, Mittra ES, Louie JD, Sze DY.

Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1192-201. doi: 10.1007/s00259-015-3048-z. Epub 2015 Apr 28.

PMID:
25916740
13.

Safety and Efficacy of Combined Yttrium 90 Resin Radioembolization with Aflibercept and FOLFIRI in a Patient with Metastatic Colorectal Cancer.

De Souza A, Daly KP, Yoo J, Saif MW.

Case Rep Oncol Med. 2015;2015:461823. doi: 10.1155/2015/461823. Epub 2015 Mar 16.

14.

Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases.

Katz SC, Burga RA, McCormack E, Wang LJ, Mooring W, Point GR, Khare PD, Thorn M, Ma Q, Stainken BF, Assanah EO, Davies R, Espat NJ, Junghans RP.

Clin Cancer Res. 2015 Apr 7. [Epub ahead of print]

PMID:
25850950
15.

Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheres.

Kennedy AS, Ball D, Cohen SJ, Cohn M, Coldwell DM, Drooz A, Ehrenwald E, Kanani S, Rose SC, Nutting CW, Moeslein FM, Savin MA, Schirm S, Putnam SG 3rd, Sharma NK, Wang EA.

J Gastrointest Oncol. 2015 Apr;6(2):134-42. doi: 10.3978/j.issn.2078-6891.2014.109.

16.

Real-Life Report on Chemoembolization Using DEBIRI for Liver Metastases from Colorectal Cancer.

Stutz M, Mamo A, Valenti D, Hausvater A, Cabrera T, Metrakos P, Chaudhury P, Steacy G, Garoufalis E, Kavan P.

Gastroenterol Res Pract. 2015;2015:715102. doi: 10.1155/2015/715102. Epub 2015 Feb 26.

17.

Outcomes of Therasphere Radioembolization for Colorectal Metastases.

Abbott AM, Kim R, Hoffe SE, Arslan B, Biebel B, Choi J, El-Haddad G, Kis B, Sweeney J, Meredith KL, Almhanna K, Strosberg J, Shibata D, Fulp WJ, Shridhar R.

Clin Colorectal Cancer. 2015 Feb 16. pii: S1533-0028(15)00031-6. doi: 10.1016/j.clcc.2015.02.002. [Epub ahead of print]

PMID:
25795047
18.

Nomogram including pretherapeutic parameters for prediction of survival after SIRT of hepatic metastases from colorectal cancer.

Fendler WP, Ilhan H, Paprottka PM, Jakobs TF, Heinemann V, Bartenstein P, Khalaf F, Ezziddin S, Hacker M, Haug AR.

Eur Radiol. 2015 Feb 28. [Epub ahead of print]

PMID:
25721320
19.

Selective transarterial radioembolisation of unresectable liver-dominant colorectal cancer refractory to chemotherapy.

Golfieri R, Mosconi C, Giampalma E, Cappelli A, Galaverni MC, Pettinato C, Renzulli M, Monari F, Mazzarotto R, Pinto C, Angelelli B.

Radiol Med. 2015 Feb 13. [Epub ahead of print]

PMID:
25678128
20.

90Yttrium PET/MR-based dosimetry after liver radioembolization (SIRT).

Wissmeyer M, Delattre BM, Zaidi H, Terraz S, Ratib O.

Clin Nucl Med. 2015 Apr;40(4):355-7. doi: 10.1097/RLU.0000000000000713.

PMID:
25674869
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk